Use of disease-modifying therapies for immune-mediated neurologic diseases remained stable from 2013 to 2022, but related costs soared, a new Medicare study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/medicare-spending-swells-neurologic-therapies-2025a1000tqa?src=rss
Author :
Publish date : 2025-10-30 13:34:00
Copyright for syndicated content belongs to the linked Source.